Do you recommend trilaciclib as primary prophylaxis for myelosuppression in certain patients with ES-SCLC treated with first line chemo-immunotherapy?

I do not routinely use growth factor support nor trilaciclib with chemotherapy or chemo-immunotherapy for people with ES-SCLC. My starting doses of chemo are usually carboplatin AUC 5 day 1 + etoposide 100 mg/m2 days 1-3, and the degree of myelosuppression and incidence of neutropenic fever with thi...